WIRE--Verastem Oncology, Upcoming Fall Investor Conferences
Digest more
Zacks Investment Research on MSN
Will Coherus Oncology (CHRS) report negative earnings next week? What you should know
Wall Street expects a year-over-year increase in earnings on higher revenues when Coherus Oncology (CHRS) reports results for the quarter ended September 2026. While this widely-known consensus ...
A pioneer of exercise oncology is bringing three decades of research out of the lab and into the lives of survivors, in ...
The partnership pairs GLOW’s education and advocacy work with Massive Bio’s platform, which will support GLOW’s programs by ...
Jazz Pharmaceuticals' strategy is starting to pay dividends.
GSK (LSE:GSK) received accelerated FDA approval for Jemperli as the first immunotherapy for certain rectal cancer patients.
AI could keep cancer evidence current, but clinical tools must be validated, traceable and governed by qualified experts.
AstraZeneca Plc AZN on Friday posted better-than-expected third-quarter 2026 results. The European drug giant reported core ...
Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Liquid Biopsy Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ...
A poster at the ASCO Quality Care Symposium describes how a value-based care partnership used prior authorization data and ...
By Sriparna Roy Oct 21 (Reuters) - Drug distributor Cencora said on Wednesday it would acquire American Oncology Network in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results